# Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study

> **NCT04815850** · — · COMPLETED · sponsor: **University of Leicester** · enrollment: 115 (actual)

## Conditions studied

- End Stage Kidney Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04815850
- **Lead sponsor:** University of Leicester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-12-05
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2024-09-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04815850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04815850, "Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04815850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*